Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IDARUCIZUMAB vs ILOPROST: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IDARUCIZUMAB vs ILOPROST: Safety Overview

Metric IDARUCIZUMAB ILOPROST
Total FAERS Reports 1,562 4,961
Deaths Reported 1,014 2,277
Death Rate 64.9% 45.9%
Hospitalizations 570 2,324
Average Patient Age 77.6 yrs 57.9 yrs
% Female Patients 42.7% 70.7%
FDA Approval Date N/A Aug 7, 2009
Manufacturer Boehringer Ingelheim Pharmaceuticals,... BTG International Inc
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Discontinued